A study by Elamir et al. demonstrated that treating HER2+ SKBR3 BC cells with doxorubicin-loaded Herceptin-liposomes resulted in enhanced internalization, as observed through fluorescence microscopy [71]. The gene discussed is ERBB2; the disease is breast cancer.